<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">

<pdf2xml producer="poppler" version="23.12.0">
<page number="1" position="absolute" top="0" left="0" height="800" width="600">
	<fontspec id="0" size="10" family="EKPFOA+MinionPro" color="#231f20"/>
	<fontspec id="1" size="9" family="EKPFOA+MinionPro" color="#231f20"/>
	<fontspec id="2" size="6" family="EKPFPB+MinionPro-Capt" color="#231f20"/>
	<fontspec id="3" size="9" family="EKPFPC+MinionMath" color="#231f20"/>
	<fontspec id="4" size="6" family="EKPGBC+MinionMath-Capt" color="#231f20"/>
	<fontspec id="5" size="8" family="EKPFOA+MinionPro" color="#231f20"/>
	<fontspec id="6" size="8" family="EKPGBC+MinionMath-Capt" color="#231f20"/>
	<fontspec id="7" size="8" family="EKPFPB+MinionPro-Capt" color="#231f20"/>
	<fontspec id="8" size="10" family="EKPFKP+MinionPro-It" color="#231f20"/>
	<fontspec id="9" size="10" family="EKPFPC+MinionMath" color="#231f20"/>
	<fontspec id="10" size="12" family="EKPFMA+Minion-Black" color="#231f20"/>
<text top="44" left="51" width="105" height="10" font="0">Journal of Transplantation</text>
<text top="44" left="544" width="5" height="10" font="0">3</text>
<text top="71" left="123" width="353" height="9" font="1">Table 2: Characteristics of donors older than 60 years according to period and transplant category.</text>
<text top="90" left="53" width="24" height="9" font="1">Period</text>
<text top="90" left="239" width="33" height="9" font="1">Pre-DKT</text>
<text top="88" left="272" width="3" height="6" font="2">a</text>
<text top="90" left="422" width="31" height="9" font="1">DKT era</text>
<text top="88" left="453" width="3" height="6" font="2">a</text>
<text top="103" left="53" width="42" height="9" font="1">Tx category</text>
<text top="103" left="245" width="16" height="9" font="1">SKT</text>
<text top="107" left="261" width="8" height="6" font="2">pre</text>
<text top="103" left="338" width="16" height="9" font="1">SKT</text>
<text top="107" left="354" width="4" height="6" font="2">lr</text>
<text top="103" left="426" width="16" height="9" font="1">SKT</text>
<text top="107" left="442" width="6" height="6" font="2">hr</text>
<text top="103" left="519" width="18" height="9" font="1">DKT</text>
<text top="114" left="54" width="5" height="12" font="3">𝑛</text>
<text top="116" left="251" width="12" height="9" font="1">170</text>
<text top="116" left="344" width="8" height="9" font="1">33</text>
<text top="116" left="434" width="7" height="9" font="1">51</text>
<text top="116" left="524" width="9" height="9" font="1">48</text>
<text top="128" left="53" width="16" height="9" font="1">M/F</text>
<text top="128" left="247" width="20" height="9" font="1">84/86</text>
<text top="128" left="339" width="17" height="9" font="1">18/15</text>
<text top="128" left="427" width="20" height="9" font="1">26/25</text>
<text top="128" left="519" width="19" height="9" font="1">27/21</text>
<text top="140" left="53" width="53" height="9" font="1">Low-risk ECD,</text>
<text top="138" left="108" width="5" height="12" font="3">𝑛</text>
<text top="140" left="253" width="9" height="9" font="1">48</text>
<text top="140" left="344" width="8" height="9" font="1">33</text>
<text top="153" left="62" width="39" height="9" font="1">(i) Age, yrs</text>
<text top="153" left="240" width="15" height="9" font="1">64.2</text>
<text top="151" left="257" width="5" height="12" font="3">±</text>
<text top="153" left="264" width="10" height="9" font="1">2.8</text>
<text top="153" left="331" width="15" height="9" font="1">63.8</text>
<text top="151" left="348" width="5" height="12" font="3">±</text>
<text top="153" left="355" width="10" height="9" font="1">2.5</text>
<text top="165" left="53" width="56" height="9" font="1">High-risk ECD,</text>
<text top="163" left="111" width="5" height="12" font="3">𝑛</text>
<text top="165" left="251" width="11" height="9" font="1">103</text>
<text top="165" left="434" width="7" height="9" font="1">51</text>
<text top="165" left="524" width="9" height="9" font="1">48</text>
<text top="178" left="62" width="39" height="9" font="1">(i) Age, yrs</text>
<text top="175" left="101" width="4" height="8" font="4">∗</text>
<text top="178" left="240" width="14" height="9" font="1">67.2</text>
<text top="176" left="256" width="5" height="12" font="3">±</text>
<text top="178" left="263" width="11" height="9" font="1">4.7</text>
<text top="178" left="421" width="13" height="9" font="1">71.2</text>
<text top="176" left="436" width="5" height="12" font="3">±</text>
<text top="178" left="443" width="11" height="9" font="1">5.4</text>
<text top="178" left="511" width="14" height="9" font="1">75.3</text>
<text top="176" left="527" width="5" height="12" font="3">±</text>
<text top="178" left="535" width="11" height="9" font="1">4.8</text>
<text top="190" left="62" width="104" height="9" font="1">(ii) Donors older than 70 yrs,</text>
<text top="188" left="168" width="5" height="12" font="3">𝑛</text>
<text top="190" left="175" width="13" height="9" font="1">(%)</text>
<text top="190" left="246" width="23" height="9" font="1">32 (31)</text>
<text top="190" left="424" width="25" height="9" font="1">32 (63)</text>
<text top="187" left="448" width="2" height="8" font="4">∘</text>
<text top="190" left="514" width="25" height="9" font="1">43 (69)</text>
<text top="187" left="539" width="2" height="8" font="4">∘</text>
<text top="203" left="62" width="121" height="9" font="1">(iii) Donors older than 70 yrs, age</text>
<text top="203" left="241" width="13" height="9" font="1">73.1</text>
<text top="201" left="256" width="5" height="12" font="3">±</text>
<text top="203" left="263" width="11" height="9" font="1">2.0</text>
<text top="203" left="421" width="15" height="9" font="1">74.4</text>
<text top="201" left="437" width="5" height="12" font="3">±</text>
<text top="203" left="445" width="10" height="9" font="1">4.1</text>
<text top="203" left="509" width="15" height="9" font="1">76.6</text>
<text top="201" left="526" width="5" height="12" font="3">±</text>
<text top="203" left="534" width="10" height="9" font="1">3.7</text>
<text top="200" left="544" width="2" height="8" font="4">∘</text>
<text top="215" left="62" width="92" height="9" font="1">(iv) Arterial hypertension</text>
<text top="215" left="245" width="24" height="9" font="1">55 (53)</text>
<text top="215" left="425" width="25" height="9" font="1">23 (45)</text>
<text top="215" left="515" width="25" height="9" font="1">30 (62)</text>
<text top="228" left="62" width="43" height="9" font="1">(v) Diabetes</text>
<text top="228" left="249" width="17" height="9" font="1">9 (9)</text>
<text top="228" left="427" width="20" height="9" font="1">5 (10)</text>
<text top="228" left="518" width="20" height="9" font="1">6 (12)</text>
<text top="240" left="62" width="80" height="9" font="1">(vi) CV cause of death</text>
<text top="240" left="244" width="26" height="9" font="1">60 (58)</text>
<text top="240" left="424" width="23" height="9" font="1">17 (33)</text>
<text top="237" left="447" width="4" height="8" font="4">+</text>
<text top="240" left="515" width="25" height="9" font="1">23 (48)</text>
<text top="252" left="51" width="3" height="6" font="2">a</text>
<text top="254" left="54" width="495" height="8" font="5">“pre-DKT”, 1 Jan, 2000, to 30 Nov, 2010; “DKT era”, 1 Dec, 2010–31 Dec, 2015; SKT: solitary kidney transplant; suffix defines donor type: ECD: ECD from</text>
<text top="263" left="51" width="498" height="8" font="5">pre-DKT era, clinical risk undefined; lr, hr: ECD according to clinical low (no biopsy) or high risk (with kidney biopsy); DKT: dual kidney transplant; CV:</text>
<text top="273" left="51" width="52" height="8" font="5">cerebrovascular;</text>
<text top="269" left="104" width="4" height="8" font="4">∗</text>
<text top="271" left="109" width="12" height="10" font="6">𝑃 &lt;</text>
<text top="273" left="122" width="74" height="8" font="5">0.0001 by ANOVA, and</text>
<text top="271" left="199" width="12" height="10" font="6">𝑃 &lt;</text>
<text top="273" left="213" width="146" height="8" font="5">0.05 or less by any intercategory comparisons;</text>
<text top="269" left="360" width="2" height="8" font="4">∘</text>
<text top="271" left="363" width="12" height="10" font="6">𝑃 &lt;</text>
<text top="273" left="377" width="34" height="8" font="5">0.01 versus</text>
<text top="273" left="413" width="16" height="8" font="7">ECD</text>
<text top="276" left="428" width="8" height="6" font="2">pre</text>
<text top="273" left="437" width="2" height="8" font="5">;</text>
<text top="269" left="440" width="4" height="8" font="4">+</text>
<text top="271" left="445" width="12" height="10" font="6">𝑃 &lt;</text>
<text top="273" left="459" width="35" height="8" font="5">0.05 versus</text>
<text top="273" left="495" width="16" height="8" font="7">ECD</text>
<text top="276" left="511" width="8" height="6" font="2">pre</text>
<text top="273" left="520" width="2" height="8" font="5">.</text>
<text top="303" left="51" width="240" height="10" font="0">a standard of care-based, anonymous study, no approval by</text>
<text top="315" left="51" width="189" height="10" font="0">ethics committee was needed in our institution.</text>
<text top="336" left="51" width="82" height="10" font="8"><i>2.2. Study Outcomes.</i></text>
<text top="336" left="137" width="153" height="10" font="0">For every donor-recipient pair, in each</text>
<text top="348" left="51" width="240" height="10" font="0">donor category, we collected and analyzed age, sex, HLA</text>
<text top="359" left="51" width="240" height="10" font="0">mismatches (loci A, B, and DRB1), type and length of dialysis,</text>
<text top="371" left="51" width="240" height="10" font="0">plasma creatinine and eGFR of donor, plasma creatinine and</text>
<text top="382" left="51" width="240" height="10" font="0">creatinine clearance (24-hour urine) at 3 months and 1 year</text>
<text top="393" left="51" width="240" height="10" font="0">after transplant, and biopsy-proven rejection of any type in</text>
<text top="405" left="51" width="240" height="10" font="0">the first 18 months after transplantation in recipients. Main</text>
<text top="416" left="51" width="240" height="10" font="0">outcomes were death-censored graft survival (i.e., freedom</text>
<text top="427" left="51" width="240" height="10" font="0">from dialysis or retransplantation) and overall graft survival</text>
<text top="439" left="51" width="240" height="10" font="0">(including death as a cause of graft loss, i.e., patients alive with</text>
<text top="450" left="51" width="240" height="10" font="0">functioning graft); as secondary outcomes we also evaluated</text>
<text top="462" left="51" width="240" height="10" font="0">PNF (no dialysis-freedom, or need for permanent dialysis</text>
<text top="473" left="51" width="240" height="10" font="0">within 3 months after transplant), DGF (need for dialysis for</text>
<text top="484" left="51" width="240" height="10" font="0">any cause in the first week after transplant), patient death</text>
<text top="496" left="51" width="240" height="10" font="0">with functioning graft, and renal function in recipients at 3</text>
<text top="507" left="51" width="240" height="10" font="0">and 12 months after transplant. Additionally, mean number</text>
<text top="518" left="51" width="240" height="10" font="0">of functioning graft years by transplant reference, and of</text>
<text top="530" left="51" width="240" height="10" font="0">dialysis-free life years by donor reference, were also calculated</text>
<text top="541" left="51" width="113" height="10" font="0">at specific times (see below).</text>
<text top="563" left="51" width="133" height="10" font="8"><i>2.3. Immunosuppression Protocols.</i></text>
<text top="563" left="189" width="102" height="10" font="0">Immunosuppression pro-</text>
<text top="574" left="51" width="240" height="10" font="0">tocols at our Centre did not change in all observation period</text>
<text top="585" left="51" width="240" height="10" font="0">(Jan 2000 to Dec 2015) and included in most patients rATG</text>
<text top="597" left="51" width="185" height="10" font="0">induction (3.5 mg/Kg in 7 days, 7 mg/Kg if</text>
<text top="595" left="241" width="6" height="13" font="9">≥</text>
<text top="597" left="247" width="44" height="10" font="0">2nd trans-</text>
<text top="608" left="51" width="240" height="10" font="0">plant), cyclosporine-A starting from pretransplantation as</text>
<text top="620" left="51" width="240" height="10" font="0">a 10 mg/Kg oral load, Mycophenolate mofetil/Mycophenolic</text>
<text top="631" left="51" width="240" height="10" font="0">acid starting on p.o. day 1 (1 g or 720 mg bid), and corticos-</text>
<text top="642" left="51" width="240" height="10" font="0">teroids (methylprednisolone 500 mg at reperfusion, rapidly</text>
<text top="654" left="51" width="240" height="10" font="0">tapered down to 8 mg/day on p.o. day 11 and 4 mg/day after</text>
<text top="665" left="51" width="240" height="10" font="0">3 months); a minority of patients (less than 10%), enrolled in</text>
<text top="676" left="51" width="240" height="10" font="0">clinical studies, might have been induced with Basiliximab</text>
<text top="688" left="51" width="240" height="10" font="0">and/or treated with Tacrolimus, Everolimus, or Sirolimus as</text>
<text top="699" left="51" width="240" height="10" font="0">alternatives; Azathioprine was also substituted for Mycophe-</text>
<text top="711" left="51" width="240" height="10" font="0">nolate in gastrointestinal intolerant patients. Posttransplant</text>
<text top="722" left="51" width="240" height="10" font="0">heparin anticoagulation was started in 2011 only in DKT,</text>
<text top="733" left="51" width="240" height="10" font="0">and after that a higher than usual graft vein thrombosis was</text>
<text top="303" left="309" width="240" height="10" font="0">observed in this type of transplant, as described also by others</text>
<text top="315" left="309" width="17" height="10" font="0"><a href="">[18].</a></text>
<text top="337" left="309" width="55" height="10" font="8"><i>2.4. Statistics.</i></text>
<text top="337" left="368" width="180" height="10" font="0">Descriptive statistics are given as numbers,</text>
<text top="348" left="309" width="94" height="10" font="0">percentages, and mean (</text>
<text top="346" left="403" width="6" height="13" font="9">±</text>
<text top="348" left="409" width="140" height="10" font="0">SD) or median (and IQR) according</text>
<text top="360" left="309" width="240" height="10" font="0">to data distribution; intercategory differences were checked</text>
<text top="371" left="309" width="240" height="10" font="0">by ANOVA followed by Scheff´e post hoc test; the chi-</text>
<text top="382" left="309" width="240" height="10" font="0">square method was used for comparison of frequencies of</text>
<text top="394" left="309" width="240" height="10" font="0">categorical data. Survival analysis was estimated as event-</text>
<text top="405" left="309" width="240" height="10" font="0">free cumulative survival using the Kaplan-Meier method and</text>
<text top="416" left="309" width="240" height="10" font="0">compared using the log-rank Mantel-Cox test. Cox regression</text>
<text top="428" left="309" width="240" height="10" font="0">analysis was used to calculate hazard ratios of cumulative</text>
<text top="439" left="309" width="240" height="10" font="0">incidence of events within each transplant category, and to</text>
<text top="451" left="309" width="240" height="10" font="0">calculate relative risks associated with patient and donor</text>
<text top="462" left="309" width="59" height="10" font="0">characteristics.</text>
<text top="473" left="324" width="225" height="10" font="0">We estimated the mean number of years in which the</text>
<text top="485" left="309" width="240" height="10" font="0">allografts were functioning before loss for any cause (failure</text>
<text top="496" left="309" width="240" height="10" font="0">or death with functioning graft) by the restricted mean</text>
<text top="507" left="309" width="240" height="10" font="0">survival analysis <a href="">[19–21</a>]; it is computed as the total area</text>
<text top="519" left="309" width="240" height="10" font="0">under the survival curve at specific times (we repeated the</text>
<text top="530" left="309" width="240" height="10" font="0">procedure at 1, 3, and 5 posttransplant years). Conceptually,</text>
<text top="541" left="309" width="240" height="10" font="0">this procedure indicates the mean time (years) each graft</text>
<text top="553" left="309" width="240" height="10" font="0">remained functional at any defined time and equals the mean</text>
<text top="564" left="309" width="240" height="10" font="0">dialysis-free life years for every recipient at any defined time.</text>
<text top="576" left="309" width="240" height="10" font="0">From this value we extrapolated total dialysis-free life years</text>
<text top="587" left="309" width="240" height="10" font="0">for every 100 donors at any time in our pre-DKT and the</text>
<text top="598" left="309" width="240" height="10" font="0">DKT protocols; for this calculation each donor was made</text>
<text top="610" left="309" width="240" height="10" font="0">equal to 1.6 SKT (according to data of our regional agency on</text>
<text top="621" left="309" width="240" height="10" font="0">utilization of overall retrieved grafts) <a href="">[22] </a>or 1 DKT according</text>
<text top="632" left="309" width="52" height="10" font="0">to allocation.</text>
<text top="644" left="324" width="225" height="10" font="0">SPSS Statistics software v.21 was used for all analyses.</text>
<text top="655" left="309" width="43" height="10" font="0">Two-tailed</text>
<text top="653" left="354" width="6" height="13" font="9">𝑃</text>
<text top="655" left="362" width="25" height="10" font="0">values</text>
<text top="653" left="389" width="6" height="13" font="9">&lt;</text>
<text top="655" left="397" width="129" height="10" font="0">0.05 were considered significant.</text>
<text top="678" left="309" width="49" height="11" font="10"><b>3. Results</b></text>
<text top="699" left="309" width="240" height="10" font="0">Summary data of all ECD and transplant categories are</text>
<text top="711" left="309" width="240" height="10" font="0">given in Table <a href="">2: </a>donor sex distribution did not differ within</text>
<text top="722" left="309" width="240" height="10" font="0">each transplant category; donor age was similar in “low-</text>
<text top="733" left="309" width="240" height="10" font="0">risk” donors of either era, while it was statistically different</text>
</page>
</pdf2xml>
